ClinicalTrials.gov registrations
health.trials
Trial registrations for the drug candidates behind these approvals — join by generic_name/intervention.
480K records · 2016–present
One row per application-submission approval event: NDA/ANDA/BLA originals and their approved supplements, with sponsor, brand/generic names, dosage form, route, active ingredients, submission class, and an is_novel flag for new molecular entities / novel biologics. Join generic_name to health.trials interventions to trace trial → approval, or sponsor_name to fda.warning_letters for regulatory risk.
Records
186,409
Approval-submission events, structured JSON
History
1939–2026
1939-02-09 through 2026-07-15
New records
Nightly batch
openFDA Drugs@FDA export refresh
Freshness
Daily
JSON · Public · included in subscription
Live-verified 2026-07-19: 186,409 records synced, 1939-02-09 through 2026-07-15.
sponsorstringApplicant/sponsor company, partial match
drugstringBrand OR generic name, partial match (searches both)
is_novelbooleanFilter to new molecular entities / novel biologics
submission_typestringORIG (original approval) or SUPPL (supplement), exact match
approval_after / approval_beforeISO dateApproval-date window
limitintegerMax records to return (default 25, max 50)
Also available: brand, generic (narrower single-field matches). Results are ordered by approval_date desc.
{
"tool": "fda.approvals",
"params": {
"is_novel": true,
"approval_after": "2025-01-01",
"limit": 25
}
}
| Field | Type | Description |
|---|---|---|
| application_number / application_type | string | NDA/ANDA/BLA number and type |
| sponsor_name | string | Applicant company — join key to fda.warning_letters |
| submission_type / submission_number | string | ORIG or SUPPL, and the submission sequence number |
| submission_class_description | string | FDA's own classification of the submission |
| review_priority | string | Priority vs. standard review |
| approval_date / approval_year | date / integer | Approval date; default sort key |
| brand_name / generic_name / substance_name | string | Marketed brand, generic, and active substance names — generic_name is the join key to health.trials |
| dosage_form / route / active_ingredients | string | Formulation detail |
| marketing_status | string | Current marketing status |
| is_novel | boolean | New molecular entity / novel biologic flag, filterable |
| is_original_approval / is_orphan | boolean | First approval and orphan-drug-designation flags |
| approval_letter_url | string | Link to the FDA approval letter — cite this |
{
"application_number": "NDA218000",
"application_type": "NDA",
"sponsor_name": "EXAMPLE PHARMA",
"submission_type": "ORIG",
"submission_number": "1",
"submission_class_description": "Type 1 - New Molecular Entity",
"review_priority": "PRIORITY",
"approval_date": "2024-06-10",
"approval_year": 2024,
"brand_name": "NOVELIQ",
"generic_name": "EXAMPLICIB",
"dosage_form": "TABLET",
"route": "ORAL",
"marketing_status": "Prescription",
"is_novel": true,
"is_original_approval": true,
"is_orphan": false
}
health.trials
Trial registrations for the drug candidates behind these approvals — join by generic_name/intervention.
480K records · 2016–present
fda.warning_letters
Active FDA enforcement against a sponsor — join by sponsor_name/company_name for a regulatory-risk screen.
964 letters · 2021–present
health.nih_grants
SBIR/STTR-funded biotechs — trace an early NIH grant through to the drug it ultimately got approved.
791K records · FY1970–present